Intrepid Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62M Buy
4,607
+26
+0.6% +$9.27K 0.62% 53
2025
Q4
$1.5M Buy
4,581
+408
+10% +$129K 0.58% 55
2025
Q3
$1.18M Buy
4,173
+680
+19% +$197K 0.46% 57
2025
Q2
$975K Buy
3,493
+468
+15% +$133K 0.4% 62
2025
Q1
$943K Buy
3,025
+819
+37% +$242K 0.46% 56
2024
Q4
$575K Buy
2,206
+462
+26% +$137K 0.29% 57
2024
Q3
$562K Buy
1,744
+110
+7% +$36K 0.31% 66
2024
Q2
$511K Buy
1,634
+584
+56% +$172K 0.33% 64
2024
Q1
$299K Buy
1,050
+137
+15% +$40.1K 0.19% 75
2023
Q4
$263K Buy
913
+546
+149% +$149K 0.18% 71
2023
Q3
$98.6K Buy
367
+7
+2% +$1.75K 0.07% 103
2023
Q2
$79.8K Buy
+360
New +$83.5K 0.06% 106

Other funds holding AMGN

Intrepid Capital Management's AMGN Position: Q1 2026 in Review

Intrepid Capital Management increased its Amgen (AMGN) stake by 0.57% in Q1 2026, buying an estimated $9.27K and bringing the position to 4,607 shares worth $1.62M. The position accounts for 0.62% of the portfolio, ranked #53.

Intrepid Capital Management first reported a position in AMGN in Q2 2023 and has held it in 12 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Intrepid Capital Management held 4,607 shares of Amgen worth $1.62M as of Q1 2026.
  • Intrepid Capital Management bought 26 Amgen shares in Q1 2026, an estimated $9.27K.
  • Amgen made up 0.62% of Intrepid Capital Management's portfolio in Q1 2026, its #53 holding.
  • Intrepid Capital Management first reported a position in Amgen in Q2 2023 and has held it in 12 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Intrepid Capital Management's 13F filing for Q1 2026, filed 15 May 2026.